Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04805450
Other study ID # ES vs noES-1
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 1, 2015
Est. completion date December 31, 2023

Study information

Verified date March 2023
Source Istituto Clinico Humanitas
Contact Andrea Anderloni, MD, PhD
Phone 00390282247308
Email andrea.anderloni@humanitas.it
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Placement of biliary self expanding metal stent (SEMS) is indicated when malignant common bile duct obstruction is encountered [1]. Currently, there is still controversy regarding the use of endoscopic sphincterotomy (EST) before the placement of biliary stents [2-5]. The aim of this prospective randomized, multicenter study is to investigate the role of EST before fully covered SEMS placement in patients with neoplastic biliary obstruction.


Recruitment information / eligibility

Status Recruiting
Enrollment 1075
Est. completion date December 31, 2023
Est. primary completion date December 31, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility - Inclusion criteria - Patients referred for endoscopic retrograde cholangiopancreatography - Malignant bile duct obstruction - Signed written informed consent - Age > 18 - Exclusion criteria - Inability to provide inform consent - Pregnancy or lactation - Suspected perforation of the GI tract - Anatomical alterations due to previous surgery (Billroth surgery) - Coagulation alterations

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
ES before fully covered SEMS placement

no ES before fully covered SEMS placement


Locations

Country Name City State
Italy Istituto Clinico Humanitas Rozzano Milano

Sponsors (1)

Lead Sponsor Collaborator
Istituto Clinico Humanitas

Country where clinical trial is conducted

Italy, 

References & Publications (5)

Artifon EL, Sakai P, Ishioka S, Marques SB, Lino AS, Cunha JE, Jukemura J, Cecconello I, Carrilho FJ, Opitz E, Kumar A. Endoscopic sphincterotomy before deployment of covered metal stent is associated with greater complication rate: a prospective randomized control trial. J Clin Gastroenterol. 2008 Aug;42(7):815-9. doi: 10.1097/MCG.0b013e31803dcd8a. — View Citation

Cui PJ, Yao J, Zhao YJ, Han HZ, Yang J. Biliary stenting with or without sphincterotomy for malignant biliary obstruction: a meta-analysis. World J Gastroenterol. 2014 Oct 14;20(38):14033-9. doi: 10.3748/wjg.v20.i38.14033. — View Citation

Dumonceau JM, Tringali A, Blero D, Deviere J, Laugiers R, Heresbach D, Costamagna G; European Society of Gastrointestinal Endoscopy. Biliary stenting: indications, choice of stents and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy. 2012 Mar;44(3):277-98. doi: 10.1055/s-0031-1291633. Epub 2012 Feb 1. — View Citation

Giorgio PD, Luca LD. Comparison of treatment outcomes between biliary plastic stent placements with and without endoscopic sphincterotomy for inoperable malignant common bile duct obstruction. World J Gastroenterol. 2004 Apr 15;10(8):1212-4. doi: 10.3748/wjg.v10.i8.1212. — View Citation

Simmons DT, Petersen BT, Gostout CJ, Levy MJ, Topazian MD, Baron TH. Risk of pancreatitis following endoscopically placed large-bore plastic biliary stents with and without biliary sphincterotomy for management of postoperative bile leaks. Surg Endosc. 2008 Jun;22(6):1459-63. doi: 10.1007/s00464-007-9643-8. Epub 2007 Nov 20. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary To assess the need for ES before SEMS placement in patients with malignant bile duct obstruction. During procedure
Secondary To evaluate immediate and delayed post ERCP complications including pancreatitis, SEMS migration, bleeding and perforation. periprocedural and 30 days